Abstract
Women and clinicians have long been aware of changes in mental and physical states related to the menstrual cycle. These changes, first described by Frank (1931) as premenstrual feelings consisting of “indescribable tension, irritability,” and “a desire to find relief by foolish and ill-considered actions,” came to be called the premenstrual tension syndrome. Since tension is only one of the components occurring during this period, the term “premenstrual syndrome” is currently preferred, since it more completely encompasses somatic and psychological components. A recent review (Steiner and Carroll, 1977) offers “premenstrual dysphoria” as an alternative term.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams PW, Rose DP, Folkard J, et al: Effects of vitamin B6 upon depression associated with oral contraception. Lancet 1: 897–900, 1973.
Albertson P: The new arterial bypass that reverses organic impotence. Sexual Med Today 3:8–13, January 29, 1979.
Altschule, MD, Brem J: Periodic psychoses of puberty. Am J Psychiatry 119: 1176–1178, 1963.
Anonymous: Endocrine basis for sexual dysfunction in men. Br Med J 2: 1516–1517, 1978.
Anonymous: Do drugs cause impotence by lowering penile blood flow? Med World News 20:85, February 19, 1979a.
Anonymous: VA study ties zinc deficiency to male infertility. Med World News 20:12, June 11, 1979b.
Antoniou LD, Shalhoub RJ, Sudhakar T, et al: Reversal of uraemic impotence by zinc. Lancet 2: 895–898, 1977.
Astwood EB: Estrogens and progestins, in Goodman L, Gilman A (eds): The Pharmacological Basis of Therapeutics, ed 4. New York, Macmillan, 1970, pp 1550–1557.
Ayd F: Oral contraceptives—psychic effects. Int Drug Ther News 1: 3–4, 1966.
Bakker CB, Dightman CR: Side effects of oral contraceptives. Obstet Gynecol 28: 373–379, 1966.
Barry JM, Hodges CV: Impotence: A diagnostic approach. J Urol 119: 575–578, 1978.
Baumblatt MJ, Winston F: Pyridoxine and the pill. Lancet 1: 832–833, 1970.
Belmaker RH, Murphy DL, Wyatt RJ, et al: Human platelet monoamine oxidase changes during the menstrual cycle. Arch Gen Psychiatry 31: 553–556, 1974.
Benedek T, Rubenstein B: The correlations between ovarian activity and psychodynamic processes: I. The ovulative phase. Psychosom Med 1: 245–270, 1939a.
Benedek, T, Rubenstein B: The correlations between ovarian activity and psychodynamic processes: II. The menstrual phase. Psychosom Med 1: 461–485, 1939b.
Benedek-Jaszmann LJ, Hearn-Sturtevant MD: Premenstrual tension and functional infertility. Lancet 1: 1095–1098, 1976.
Billetiere E, Fluckiger E: Evidence for a luteolytic function intact cyclic rat using 2-BR-alphaergocryptine (B-154). Experiencia (Basel) 27: 464–466, 1971.
Brown-Parlee M: The premenstrual syndrome. Psychol Bull 80: 454–465, 1973.
Bunney WE, Brodie KH, Murphy DL, et al: Studies of alpha-methyl-para-tyrosine, L-dopa and Ltryptophan in depression and mania. Am J Psychiatry 127: 872–881, 1971.
Carroll BJ, Steiner M: The psychobiology of premenstrual dysphoria: The role of prolactin. Psychoneuroendocrinology 3: 171–180, 1978.
Chopp RT, Mendez R: Sexual function and hormonal abnormalities in uremic men on chronic dialysis and after renal transplantation. Fertil Steril 29: 661–666, 1978.
Claiber EL, Kobayashi Y, Groverman DM, et al: Plasma monoamine oxidase activity in regularly menstruating women and in amenorrheic women receiving cyclic treatment with estrogens and a progestin. J Clin Endocrinol Metab 33: 630–637, 1971.
Cooke WR: The differential psychology of the American woman. Am J Obstet Gynecol 49: 457–460, 1945.
Coppen A, Kessel N: Menstruation and personality. Br J Psychiatry 109: 711–721, 1963.
Coppen AJ, Milne HB, Autran DH, et al: Dytide, norethisterone and a placebo in the premenstrual syndrome—a double-blind comparison. Clin Trials J 6: 33–36, 1969.
Cullberg J: Mood changes and menstrual symptoms with different progestagen/estrogen combinations. Acta Psychiatr Scand 236 (suppl): 1–84, 1972.
Dalton K: Menstruation and acute psychiatric illness. Br Med J 1: 148–149, 1959.
Dalton K: Menstruation and crime. Br Med J 2: 1752–1753, 1961.
Dalton K: The Premenstrual Syndrome. Springfield, Charles C Thomas, 1964.
Dalton K: The influence of a mother’s menstruation on her child. Proc R SocMed 59: 1014–1015, 1966.
Dalton K: Prospective study into puerperal depression. Br J Psychiatry 118: 689–692, 1971.
Davis RE, Smith BK: Pyridoxine and depression associated with oral contraception. Lancet 1: 1245, 1973.
Deutsch H: Psychology of Women. London, Research Books, 1944, p 118.
Endo M, Daiguji M, Wytaka A, et al: Periodic psychoses reoccurring in association with menstrual cycle. J Clin Psychiatry 39: 456–461, 465–466, 1978.
Fisher C, Schiavi RC, Edwards A, et al: Evaluation of nocturnal penile tumescence in the differential diagnosis of sexual impotence. Arch Gen Psychiatry 36: 431–437, 1979.
Fleming O, Seager CP: Incidence of depressive symptoms in users of the oral contraceptive. Br J Psychiatry 132: 431–440, 1978.
Frank RT: The hormonal causes of premenstrual tension. Arch Neurol Psychiatry (Chicago) 26: 1053–1055, 1931.
Fries H: Experience with lithium carbonate treatment at a psychiatric department in the period 1964–1967. Acta Psychiatr Scand 207 (suppl): 41–43, 1969.
Gilmore NJ, Robinson DS, Nies A, et al: Monoamine oxidase levels in pregnancy and during the menstrual cycle. J Psychosom Res 15: 215–220, 1971.
Glass JS, Heninger GR, Lansky N, et al: Psychiatric emergency related to the menstrual cycle. Am J Psychiatry 128: 705–711, 1971.
Glick ID: Mood and behavioral changes associated with the use of the oral contraceptive agents: A review of the literature. Psychopharmacologia 10: 363–374, 1967.
Goldzieher JW, Moses LE, Averkine E, et al: Nervousness and depression attributable to oral contraceptives: A double-blind placebo-controlled study. Am J Obstet Gynecol 111: 1013–1020, 1971.
Gonzalez ER: Hyperprolactinemia: Still perplexing but eminently treatable. DAMA 242: 401–409, 1979.
Grant ECG, Pryse-Davies J: Effects of oral contraceptives on depressive mood changes and on endometrial monoamine oxidase and phosphatases. Br Med J 3: 777–780, 1968.
Greene R, Dalton K: The premenstrual syndrome. Br Med J 1: 1007–1008, 1953.
Gregory BAJC: The menstrual cycle and its disorders in psychiatric patients: I. Review of the literature. J Psychosom Res 2: 61–66, 1957.
Hartoma TR, Nahoul K, Netter A: Zinc, plasma androgens and male sterility. Lancet 2: 1125–1126, 1977.
Heggarty AB: Post-puerperal recurrent depression. Br Med J 1: 637–640, 1955.
Herzberg B, Coppen A: Changes in psychological symptoms in women taking oral contraceptives. Br J Psychiatry 116: 161–164, 1970.
Herzberg BN, Draper KC, Johnson AL, et al: Oral contraceptives, depression and libido. Br Med J 3: 495–500, 1971.
Herzberg BN, Johnson AL, Brown S: Depressive symptoms in oral contraceptives. Br Med J 4: 142–145, 1970.
Hood WE, Bond WL: Enovid therapy for premenstrual tension. Obstet Gynecol 14: 239–241, 1959.
Horowitz JD, Goble AJ: Drugs and impaired male sexual function. Drugs 18: 206–207, 1979.
Horrobin DF, Manku MF, Massar B, et al: Prolactin and fluid and electrolyte balance, in Pasteels JL, Robyn C (eds): Human Prolactin. Amsterdam, Excerpta Medica, 1973, pp 152–155.
Jacobs TI, Charles E: Correlation of psychiatric symptomatology in an outpatient population. Am J Psychiatry 126: 1504–1508, 1970.
Janowsky DS, Berens S, Davis JM: Correlations between mood, weight and electrolytes during the menstrual cycle: A renin–angiotensin–aldosterone hypothesis of premenstrual tension. Psychosom Med 35: 143–154, 1973.
Janowsky DS, Gorney R, Kelly B: “The Curse:” Vicissitudes and variations of the female fertility cycle. Psychosomatics 7: 242–247, 1966.
Janowsky DS, Gorney R, Mandell AJ: The menstrual cycle. Psychiatric and ovarian–adrenocortical hormone correlates: Case study and literature review. Arch Gen Psychiatry 17: 459–464, 1967.
Jordheim O: The premenstrual syndrome—clinical trials of treatment with a progesterone combined with a diuretic compared with both a progesterone and with a placebo. Acta Obstet Gynecol Scand 51: 77–80, 1972.
Kane FJ: Psychiatric reactions to oral contraceptives. Am J Obstet Gynecol 102: 1053–1063, 1968.
Kane FJ, Keeler MH: Use of Enovid in post-partum mental disorders. South Med 158: 1089–1092, 1965.
Karacan I, Salis PJ, Williams RL: The role of the sleep laboratory in diagnosis and treatment of impotence, in Williams RL, Karacan I (eds): Sleep Disorders, Diagnosis and Treatment. New York, John Wiley and Sons, 1978a, pp 353–382.
Karacan I, Ware JC, Dervent B, et al: Impotence and blood pressure in the flaccid penis: Relationship to nocturnal penile tumescence. Sleep 1: 125–132, 1978b.
Kashiwagi T, McClure JN, Wetzel RD: Premenstrual affective syndrome and psychiatric disorder. Dis Nery Syst 37: 116–119, 1976.
Kaya N, Moore, Karacan I: Nocturnal penile tumescence and its role in impotence. Psychiatr Ann 9: 426–431, 1979.
Keeler MH, Daly R, Kane FJ: An acute schizophrenic episode following the abrupt withdrawal of Enovid in a patient with previous post-partum psychiatric disorder. Am J Psychiatry 121:1123–1124, 1964.
Kotin J, Wilbert DE, Verburg D, et al: Thioridazine and sexual dysfunction. Am J Psychiatry 113: 82–85, 1976.
Kramer MS: Menstrual epileptoid psychosis in an adolescent girl. Am J Dis Child 131: 316–317, 1977.
Kramp JL: Studies of the premenstrual syndrome in relation to psychiatry. Acta Psychiatr Scand 203 (suppl): 261–267, 1968.
Kutner SJ, Brown WL: Types of oral contraceptives, depression and premenstrual symptoms. J Nery Ment Dis 155: 153–162, 1972a.
Kutner SJ, Brown WL: History of depression as a risk factor for depression with oral contraceptives and discontinuance. J Nery Ment Dis 155: 163–169, 1972b.
Laidlow J: Catamenial epilepsy. Lancet 2: 1235–1237, 1956.
Leeton J: The relation between oral contraception and depression. Aust N Z J Obstet Gynecol 13: 115–118, 1973.
Lewis A, Hoghughi M: An evaluation of depression as a side effect of oral contraceptives. Br J Psychiatry 115: 697–701, 1969.
Logothetics J, Herner R, Morrell F, et al: The role of estrogen in catamenial exacerbation of epilepsy. Neurology 9: 352–360, 1959.
McClure JN, Reich T, Wetzel RD: Premenstrual symptoms as indicator of bi-polar affective disorder. Br J Psychiatry 119: 527–528, 1971.
MacKinnon IL, MacKinnon PC, Thompson A: Lethal hazards of the luteal phase of the menstrual cycle. Br Med J 1: 1015–1017, 1959.
Malek-Ahmadi D, Behrmann PJ: Depressive syndrome induced by oral contraceptives Dis Nery Syst 37: 406–408, 1976.
Mandell A, Mandell M: Suicide in the menstrual cycle. DAMA 200: 792–793, 1967.
Marcotte DB, Kane FG, Obrist P, et al: Psychophysiologic changes accompanying oral contraceptive use. Br J Psychiatry 116: 165–167, 1970.
Massry SG, Goldstein DA, Procci WR, et al: Impotence in patients with uremia: A possible role for parathyroid hormone. Nephron 19: 305–310, 1977.
Mattsson B, von Schoultz B: A comparison between lithium, placebo, and a diuretic in premenstrual tension. Acta Psychiatr Scand 255 (suppl): 75–84, 1974.
Mendelson JH, Mello NK: Biologic concomitants of alcoholism. N Eng J Med 301:912–921, 1979. Moos RH: Psychological aspects of oral contraceptives. Arch Gen Psychiatry 19: 87–94, 1968a.
Moos RH: The development of a menstrual distress questionnaire. Psychosom Med 30: 853–867, 19686.
Moos RH: Assessment of psychological concomitants of oral contraceptives, in Metabolic Effects of Gonadal Hormones and Contraceptive Steroids. New York, Plenum Press, 1969a, pp 676–705.
Moos RH: Typology of menstrual psychosymptoms. Am J Obstet Gynecol 103: 390–402, 1969b.
Morton JH: Premenstrual tension. Am J Obstet Gynecol 60: 343–352, 1950.
Morton JH, Addition H, Haddison RG, et al: Clinical study of premenstrual tension. Am J Obstet Gynecol 65: 1182–1191, 1953.
Murawaski B: Psychologic considerations for the evaluation of long-term use of oral contraceptives. J Reprod Med 3: 151–155, 1969.
Murawaski B, Sapir B, Shulman N, et al: Investigation of mood states in women taking oral contraceptives. Fertil Steril 19: 50–63, 1968.
Murphy RJ: Compliance dilemma: Antihypertensives and sexual dysfunction. Behav Med 12: 10–14, October 1978.
Nilsson A, Almgren PE: Psychiatric symptoms during the post-partum period as related to use of oral contraceptives. Br Med J 2:453–455, 1968.
Novell HA: Psychological factors in premenstrual tension in dysmenorrhea. Clin Obstet Gynecol 8: 222–232, 1965.
Ota Y, Mukai T, Gotoda K: Studies on the relationship between psychotic symptoms and sexual cycle. Folio Psychiatr Neurol Jpn 8:207–217 1954.
Paige KE: The effects of oral contraceptives on affective fluctuations associated with the menstrual cycle. Psychosom Med 33:515–517, 1971.
Piemme TE: Sexuality and illicit drugs. Med Asp Hum Sexuality 10:85–86 1976.
Prasad AS: Metabolism of zinc and its deficiency in human subjects, in Prasad AS (ed): Zinc Metabolism. Springfield, Charles C Thomas 1966 pp 250–303.
Rees L: Psychosomatic aspects of the premenstrual tension syndrome. Br J Psychiatry 99:162–173, 1953.
Renshaw DC: Inflatable penile prosthesis. JAMA 241:2637–2638 1979.
Ribeiro AL: Menstruation and crime. Br Med J 1:640–641 1962.
Rose DP: Oral contraceptives and depression. Lancet 2:321 1969.
Scott FB, Byrd GJ, Karacan I, et al: Erectile impotence treated with an implantable, inflatable prosthesis. JAMA 241:2609–2612 1979.
Segraves RT: Pharmacological agents causing sexual dysfunction. J Sex Marit Ther 3:157–176, 1977.
Shainess N: Psychiatric evaluation of premenstrual tension. NY State JMed 62:3573–3579,1962.
Silbergeld S, Brast N, Nobel EP: The menstrual cycle—a double-blind study of symptoms, mood and behavior and biochemical variables, using Enovid and placebo. Psychosom Med 33: 411–428, 1971.
Simpson GM, Badinger N, Rochlin D: Enovid in the treatment of psychic disturbances associated with menstruation. Dis New Syst 23:589–590 1962.
Simpson GM, Rochlin D, Kline NS: Further studies of Enovid in the treatment of psychiatric patients. Dis New Syst 25:484–488 1964.
Sletten IW, Gershon S: The premenstrual syndrome: A discussion of its pathophysiology and treatment with lithium ion. Compr Psychiatry 7:197–206 1966.
Small MP: Small-Carrion penile prosthesis: A report on 160 cases and review of the literature. J Urol 119: 365–368, 1978.
Smith SL: Mood and the menstrual cycle, in Sacher EJ (ed): Topics in Psychoendocrinology. New York, Grune & Stratton 1975 pp 19–58.
Somerville BW: The influence of progesterone and estradiol upon migraine. J Headache 12: 93–102, 1972.
Sommer B: The effect of menstruation on cognitive and perceptual–motor behavior: A review. Psychosom Med 35:515–534 1973.
Spark RF, White RA, Connolly PB: Impotence is not always psychogenic: Newer insights into hypothalamic–pituitary–gonadal dysfunction. JAMA 243:750–755 1980.
Steiner M, Carroll BJ: The psychobiology of premenstrual dysphoria: Review of theories and treatments. J Psychoneuroendocrinol 2:321–335 1977.
Stokes J, Mendels J: Pyridoxine and premenstrual tension. Lancet 1:1177–1178 1972.
Swanson DW, Burron A, Floren A, et al: The use of norethynodrel in psychotic females. Am J Psychiatry 120:1101–1103 1964.
Swyer GIM: Treatment of the premenstrual syndrome—value of ethisterone, nephinesin and a placebo compared. Br Med J 1:1410–1414 1955.
Takagi H: Periodic psychosis in preadolescence. Psychiatr Neurol Jpn 61:1194–1208, 1959.
Tonks CN, Rack PH, Rose MJ: Attempted suicide in the menstrual cycle. J Psychosom Res 11: 319–323, 1967.
Tupin JP: Lithium use in non-manic depressive condition. Compr Psychiatry 13:209–214 1972.
Varga L, Lutterbeck BM, Pryor JS, et al: Suppression of puerperal lactation with an ergot alkaloid: A double-blind study. Br Med J 2:743–744 1972.
Vinarova E, Uhlir O, Stika L, et al: Side effects of lithium administration. Activ Nery Sup 14: 105–107, 1972.
Wearing MP: The use of norethindrone (2 mg) and mestranol (1 mg) in infertility control. Can Med Assoc J 89: 239–241, 1963.
Weiss HD: The physiology of human penile erection. Ann Intern Med 76: 793–799, 1972.
Wetzel RD, Reich T, McClure JN, et al: Premenstrual affective syndrome and affective disorder. Br J Psychiatry 127: 219–221, 1975.
Whitehead RE: Women pilots. J Aviat Med 5: 47–49, 1934.
Williams EY, Weekes LR: Premenstrual tension associated with psychotic episodes. J Nery Ment Dis 116: 321–329, 1952.
Winston F: Oral contraceptives, pyridoxine and depression. Am J Psychiatry 30:1217–1221, 1973.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1981 Plenum Publishing Corporation
About this chapter
Cite this chapter
Jefferson, J.W., Marshall, J.R. (1981). Reproductive and Sexual Function Disorders. In: Neuropsychiatric Features of Medical Disorders. Critical Issues in Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3920-5_15
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3920-5_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3922-9
Online ISBN: 978-1-4684-3920-5
eBook Packages: Springer Book Archive